Prophylactic Ceftizoxime (Cefizox) for Elective Cesarean Delivery

• Status: Completed
• Trial end date: 2011-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

Ceftizoxime (Cefizox) will reduce post Cesarean delivery febrile morbidity.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Khartoum
• Collaborator: Ministry of Health, Sudan
• Treatments: Ceftizoxime

Criteria

Inclusion Criteria:

• Elective Cesarean section

Exclusion Criteria:

• Diabetes severe anaemia allergy